Yuying Liu

Yuying Liu

Auto-generated profile, based on publicly available information

Yuying Liu

State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Pharmacology, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 January 2020 in Science Immunology
Verified
Journal Article
Closed access
PDF file
YLYuying Liu
Yuying Liu
YFYiliang Fang
Yiliang Fang
XCXinfeng Chen
Xinfeng Chen
ZWZhenfeng Wang
Zhenfeng Wang
XLXiaoyu Liang
Xiaoyu Liang
BHBo Huang
Bo Huang
Cytokine release syndrome (CRS) counteracts the effectiveness of chimeric antigen receptor (CAR) T cell therapy in cancer patients, but the mechanism underlying CRS remains unclear. Here, we show that tumor cell pyroptosis triggers CRS during CAR T cell therapy. We find that CAR T cells rapidly activate caspase 3 in target cells through release of granzyme B. The latter cleaves gasdermin E (GSDME), a pore-forming protein highly expressed in B leukemic and other target cells, which results in extensive pyroptosis. Consequently, pyroptosis-released factors activate caspase 1 for GSDMD cleavage in macrophages, which results in the release of cytokines and subsequent CRS. Knocking out GSDME, depleting macrophages, or inhibiting caspase 1 eliminates CRS occurrence in mouse models. In patients, GSDME and lactate dehydrogenase levels are correlated with the severity of CRS. Notably, we find that the quantity of perforin/granzyme B used by CAR T cells rather than existing CD8+ T cells is critical for CAR T cells to induce target cell pyroptosis.

11 January 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
YLYuying Liu
Yuying Liu
NZNannan Zhou
Nannan Zhou
LZLi Zhou
Li Zhou
JWJing Wang
Jing Wang
YZYabo Zhou
Yabo Zhou
BHBo Huang
Bo Huang

13 April 2021 in Cell Discovery
Verified
Journal Article
Open access
PDF file
JLJiadi Lv
Jiadi Lv
ZWZhenfeng Wang
Zhenfeng Wang
YQYajin Qu
Yajin Qu
HZHua Zhu
Hua Zhu
QZQiangqiang Zhu
Qiangqiang Zhu
BHBo Huang
Bo Huang
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) invades the alveoli, where abundant alveolar macrophages (AMs) reside. How AMs respond to SARS-CoV-2 invasion remains elusive. Here, we show that classically activated M1 AMs facilitate viral spread; however, alternatively activated M2 AMs limit the spread. M1 AMs utilize cellular softness to efficiently take up SARS-CoV-2. Subsequently, the invaded viruses take over the endo-lysosomal system to escape. M1 AMs have a lower endosomal pH, favoring membrane fusion and allowing the entry of viral RNA from the endosomes into the cytoplasm, where the virus achieves replication and is packaged to be released. In contrast, M2 AMs have a higher endosomal pH but a lower lysosomal pH, thus delivering the virus to lysosomes for degradation. In hACE2 transgenic mouse model, M1 AMs are found to facilitate SARS-CoV-2 infection of the lungs. These findings provide insights into the complex roles of AMs during SARS-CoV-2 infection, along with potential therapeutic targets.

4 December 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JLJiadi Lv
Jiadi Lv
YLYaoping Liu
Yaoping Liu
FCfeiran cheng
feiran cheng
JLJiping Li
Jiping Li
YZYabo Zhou
Yabo Zhou
BHBo Huang
Bo Huang
Identifying and sorting highly tumorigenic and metastatic tumor cells from a heterogeneous cell population is a daunting challenge. Here, we show that microfluidic devices can be used to sort marker‐based heterogeneous cancer stem cells (CSC) into mechanically stiff and soft subpopulations. The isolated soft tumor cells (< 400 Pa) but not the stiff ones (> 700 Pa) can form a tumor in immunocompetent mice with 100 cells per inoculation. Notably, only the soft, but not the stiff cells, isolated from CD133 + , ALDH + , or side population CSCs, are able to form a tumor with only 100 cells in NOD‐SCID or immunocompetent mice. The Wnt signaling protein BCL9L is upregulated in soft tumor cells and regulates their stemness and tumorigenicity. Clinically, BCL9L expression is correlated with a worse prognosis. Our findings suggest that the intrinsic softness is a unique marker of highly tumorigenic and metastatic tumor cells.

15 January 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
YLYuying Liu
Yuying Liu
TZTianzhen Zhang
Tianzhen Zhang
HZHaizeng Zhang
Haizeng Zhang
JLJiping Li
Jiping Li
NZNannan Zhou
Nannan Zhou
BHBo Huang
Bo Huang
Biomechanics is a fundamental feature of a cell. However, the manner by which actomysin tension affects tumor immune evasion remains unclear. Here we show that although cytotoxic T lymphocytes (CTL) can effectively destroy stiff differentiated tumor cells, they fail to kill soft tumor-repopulating cells (TRC). TRC softness prevented membrane pore formation caused by CTL-released perforin. Perforin interacting with nonmuscle myosin heavy-chain 9 transmitted forces to less F-actins in soft TRC, thus generating an inadequate contractile force for perforin pore formation. Stiffening TRC allowed perforin the ability to drill through the membrane, leading to CTL-mediated killing of TRC. Importantly, overcoming mechanical softness in human TRC also enhanced TRC cell death caused by human CTL, potentiating a mechanics-based immunotherapeutic strategy. These findings reveal a mechanics-mediated tumor immune evasion, thus potentially providing an alternative approach for tumor immunotherapy. Significance: Tumor-repopulating cells evade CD8+ cytolytic T-cell killing through a mechanical softness mechanism, underlying the impediment of perforin pore formation at the immune synapse site.

6 July 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
YGYunfeng Gao
Yunfeng Gao
HZHui Zhang
Hui Zhang
NZNannan Zhou
Nannan Zhou
PXPingwei Xu
Pingwei Xu
JWJianxiong Wang
Jianxiong Wang
BHBo Huang
Bo Huang